From: Hyponatremia is a surrogate marker of poor outcome in peritoneal dialysis-related peritonitis
 | Hyponatremic group (n = 27) | Normonatremic group (n = 72) | p-value |
---|---|---|---|
Gender (M/F) | 10/17 | 48/24 | 0.015 |
Age (years) | 49.1 ± 9.9 | 52.6 ± 11.7 | 0.173 |
Duration of dialysis (years) | 4.0 ± 1.5 | 3.4 ± 1.8 | 0.148 |
Primary renal disease | Â | Â | Â |
  Chronic glomerulonephritis | 4 | 15 | 0.696 |
  Diabetic nephropathy | 9 | 28 | 0.783 |
  Hypertension | 8 | 13 | 0.328 |
  Systemic lupus erythematosus | 3 | 7 | 1.000 |
  Polycystic kidney disease | 0 | 1 | 1.000 |
  Unknown | 3 | 8 | 1.000 |
Medication | Â | Â | Â |
  Oral Hypoglycemic agent | 1 | 3 | 1.000 |
  α-adrenergic blocker | 6 | 8 | 0.197 |
  β-adrenergic blocker | 6 | 22 | 0.724 |
  Calcium channel blocker | 15 | 27 | 0.164 |
  ACEI or ARB+ | 5 | 7 | 0.185 |
  Furosemide | 2 | 6 | 1.000 |
  Na+ supplement | 0 | 0 | 1.000 |
Number of 4.25% Dialysate (bags/day) | 1.2 ± 0.8 | 1.0 ± 0.7 | 0.144 |
Duration before antibiotics delivery (day) | 1.1 ± 0.5 | 1.1 ± 0.8 | 0.148 |
Co-morbidity: Deyo-CCI++ | 3.6 ± 1.2 | 3.7 ± 1.5 | 0.755 |
Subjective global assessment score | 4.6 ± 1.2 | 5.7 ± 0.6 | <0.001 |
Nutritional status: mean nPNA* | 1.1 ± 0.3 | 1.2 ± 0.4 | 0.278 |
RRF** (mL/min/1.73 m2) | 1.2 ± 1.4 | 1.5 ± 1.5 | 0.257 |